Categories: News

AV-Comparatives Releases Consumer Summary Report 2025

Independent Testing Highlights Top-Performing Consumer Security Solutions

- Advertisement -

INNSBRUCK, Austria, Jan. 14, 2026 /PRNewswire/ — AV-Comparatives, the internationally recognised independent authority in cybersecurity testing, has published its Consumer Summary Report 2025, presenting a comprehensive overview of the performance of leading consumer security products for Windows. The report summarises a full year of rigorous, scientifically sound testing designed to help consumers identify effective and reliable cybersecurity solutions.

- Advertisement -

The Consumer Summary Report consolidates results from AV-Comparatives’ 2025 Consumer Main-Test Series, in which 19 widely used security products were evaluated. Testing covered real-world protection against live internet threats, malware detection capabilities, resistance to advanced attacks, system performance impact, and the frequency of false alarms. All tests were conducted using transparent methodologies under real-life conditions, ensuring unbiased and reproducible results.

- Advertisement -

Key Findings

- Advertisement -

Top-Rated Products 2025

Products that demonstrated consistently high performance across all test categories received AV-Comparatives’ prestigious Top-Rated Product Award. For 2025, these were: Avast Free Antivirus, AVG AntiVirus Free, Bitdefender Total Security, ESET HOME Security Essential, G DATA Total Security, Kaspersky Premium, and Norton Antivirus Plus.

- Advertisement -

Category Awards

To recognise excellence in specific areas, AV-Comparatives awarded Gold, Silver, and Bronze distinctions across individual test categories:

- Advertisement -
  • Real-World Protection: Gold – Norton; Silver – Bitdefender; Bronze – Avira, Kaspersky, McAfee
  • Malware Protection: Gold – Kaspersky; Silver – G DATA; Bronze – Bitdefender
  • Performance (Low System Impact): Gold – Avast & AVG; Silver – Norton; Bronze – McAfee
  • Advanced Threat Protection: Gold – Bitdefender & ESET
  • False Positives: Gold – Kaspersky; Silver – Total Defense; Bronze – Bitdefender

These awards reflect not only strong protection capabilities, but also a balanced approach to usability and system efficiency — essential factors for everyday users.

- Advertisement -

User Experience Review

In addition to technical testing, the report includes a structured user-interface review for each product, evaluating installation, configuration options, alerts, and overall ease of use. This ensures the assessments reflect both security effectiveness and real-world practicality.

- Advertisement -

Independent Guidance for Consumers

- Advertisement -

“The 2025 Consumer Summary Report demonstrates that many vendors continue to deliver a very high level of protection,” said Andreas Clementi, CEO and Founder of AV-Comparatives. “Our goal remains to provide independent, transparent testing that enables consumers to make well-informed security decisions based on reliable data.”

- Advertisement -

The Consumer Summary Report 2025 is available for free download at
https://www.av-comparatives.org/tests/summary-report-2025/

- Advertisement -

Logo – https://mma.prnewswire.com/media/2608678/5717793/AV_Comparatives_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/av-comparatives-releases-consumer-summary-report-2025-302661367.html

- Advertisement -

Recent Posts

Deepak Group Goes Beyond Green with hands-On Mangrove Restoration

Deepak Group undertakes mangrove plantation drive on World Environment DaySustainable restoration along the Paniyadra coast,…

3 hours ago

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

7 hours ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

7 hours ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

7 hours ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

7 hours ago